Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session


Don’t forget to check out our premarket coverage here

  • Fate Therapeutics, Inc. FATE fell 4.1% to $6.13 in pre-market trading. Fate Therapeutics is expected to report Q4 results on Tuesday, Feb. 28, 2023.
  • Cleveland-Cliffs Inc. CLF dropped 3.8% to $19.35 in pre-market trading. For the fourth quarter, the company recorded a net loss of $204 million, corresponding to a loss of $0.41 per diluted share as against a net income of $899 million, or $1.69 per diluted share in the same period of the previous quarter.
  • Vir Biotechnology, Inc. VIR fell 3.4% to $25.30 in pre-market trading. Vir Biotechnology reported amended collaboration agreement with GSK.

Now Read This: Coca-Cola All Set To Report Earnings Today; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts


Market News and Data brought to you by Benzinga APIs
Posted In: NewsSmall CapPre-Market OutlookMarketsMoversTrading Ideasbig losersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!